文献速递关节外科运动医学

临界性髋关节发育不良患者初次髋关节镜联合关节囊皱缩与盂唇保留术后十年生存率与患者报告结局

Borderline Dysplasia After Primary Hip Arthroscopy with Capsular Plication and Labral Preservation: Ten-Year Survivorship and Patient-Reported Outcomes.
PubMed 文献 · J Bone Joint Surg Am · 2023-05-03

该研究前瞻性纳入2008年9月至2011年9月接受初次髋关节镜联合关节囊皱缩与盂唇保留的临界性髋关节发育不良(BHD,LCEA 18°至25°)患者,至少10年随访显示10年生存率82.2%,所有患者报告结局指标(PROMs)和疼痛VAS较基线显著改善(p<0.001),BMI≥23 kg/m²和年龄≥42岁与更高的全髋关节置换(THA)转换风险相关,BHD组生存率、PROMs和MCID达标率与无BHD对照组相当。

要点

  • BHD患者初次髋关节镜联合关节囊皱缩与盂唇保留术后10年生存率为82.2%。
  • 所有PROMs和疼痛VAS从基线到至少10年随访显著改善(p<0.001)。
  • BMI≥23 kg/m²者THA转换风险为4.4倍,年龄≥42岁者为7.1倍。

核心结论

  • BHD患者接受初次髋关节镜联合关节囊皱缩与盂唇保留术后,至少10年随访总体生存率为82.2%,所有PROMs显著改善且MCID达标率高。

研究设计与样本

  • 前瞻性收集2008年9月至2011年9月接受初次髋关节镜患者的资料,纳入LCEA 18°至25°的BHD患者,排除同侧髋既往手术、工伤补偿状态、Tönnis分级>1、既往髋关节疾病或LCEA<18°者,56个合格髋中45个(80%)纳入,其中女性38髋(84%)、男性7髋(16%),平均年龄31.0±12.9岁,平均BMI 24.5±5.4 kg/m²,并与无BHD对照组进行倾向性匹配比较。

主要发现

  • 10年生存率为82.2%,定义为未转换为全髋关节置换(THA)。
  • 所有PROMs和疼痛VAS从基线到至少10年随访显著改善(p<0.001)。
  • BMI≥23 kg/m²患者转换为THA的几率为4.4倍,年龄≥42岁患者为7.1倍。
  • MCID达标率:mHHS 79%、NAHS 79%、HOS-SSS 70%、疼痛VAS 76%。
  • BHD组至少10年生存率、PROMs和MCID达标率与对照组相当。

关键数值与推荐

  • BHD定义为侧位中心边缘角(LCEA)在18°至25°之间。
  • 生存率定义为未转换为全髋关节置换(THA)。
  • BMI≥23 kg/m²患者转换为THA的几率为4.4倍,年龄≥42岁患者为7.1倍。
  • MCID达标率:mHHS 79%、NAHS 79%、HOS-SSS 70%、疼痛VAS 76%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The arthroscopic management of borderline hip dysplasia (BHD) is controversial, and long-term follow-up data are scarce. The purpose of this study was to report prospectively collected survivorship and patient-reported outcome measures (PROMs) at a minimum 10-year follow-up following primary hip arthroscopy with capsular plication and labral preservation in patients with BHD. METHODS: Data were prospectively collected on all patients who underwent primary hip arthroscopy between September 2008 and September 2011. Patients with BHD (defined by a lateral center-edge angle [LCEA] between 18° and 25°) were included. Preoperative and minimum 10-year follow-up scores for the modified Harris hip score (mHHS), Nonarthritic Hip Score (NAHS), Hip Outcome Score-Sports Specific Subscale (HOS-SSS), and visual analog scale (VAS) for pain were collected. Exclusion criteria were prior ipsilateral hip surgery, Workers' Compensation status, Tönnis grade of >1, previous hip conditions, or LCEA of <18°. Survivorship was defined as no conversion to total hip arthroplasty (THA). The risk factors for THA conversion were analyzed. The achievement rate for the minimal clinically important difference (MCID) was reported. A propensity-matched comparison with a control group without BHD was performed. RESULTS: Forty-five (80%) of 56 eligible hips were included in this study: 38 hips (84%) of female patients and 7 hips (16%) of male patients. The mean patient age was 31.0 ± 12.9 years, and the mean patient body mass index (BMI) was 24.5 ± 5.4 kg/m 2 . The 10-year survivorship was 82.2%, and there was significant improvement in all PROMs and VAS pain from baseline to the minimum 10-year follow-up (p < 0.001). The odds of undergoing conversion to THA were 4.4 times higher for patients with a BMI of ≥23 kg/m 2 and 7.1 times higher for patients who were ≥42 years of age. The MCID was achieved at high rates for the mHHS (79%), NAHS (79%), HOS-SSS (70%), and VAS pain (76%). The minimum 10-year survivorship, PROMs, and MCID achievement rates for the BHD group were comparable with those for the control group. CONCLUSIONS: Patients with BHD who underwent primary hip arthroscopy with capsular plication and labral preservation demonstrated an overall survivorship of 82.2% and significant improvement in all PROMs and achieved the MCID at high rates at a minimum 10-year follow-up. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Domb BG, Owens JS, Glein RM, et al. Borderline Dysplasia After Primary Hip Arthroscopy with Capsular Plication and Labral Preservation: Ten-Year Survivorship and Patient-Reported Outcomes. J Bone Joint Surg Am. 2023. PMID: 37083686. doi:10.2106/JBJS.22.00340

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。